Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Neurological disorders and treatments, Parkinson's Disease Mechanisms and Treatments, Botulinum Toxin and Related Neurological Disorders, and Genetic Neurodegenerative Diseases.
Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years
What was first and what is next in selecting device-aided therapy in Parkinson’s disease? Balancing evidence and experience
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease
Exercise Habits in People with Parkinson's: A Multinational Survey
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals
Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease
Axial Postural Abnormalities in Parkinsonism: Gaps in Predictors, Pathophysiology, and Management
Predictors and Pathophysiology of Axial Postural Abnormalities in Parkinsonism: A Scoping Review
Six Action Steps to Address Global Disparities in Parkinson Disease
Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity
Parkinson's Disease and <scp>Post–COVID</scp>‐19 Syndrome: The Parkinson's <scp>Long‐COVID</scp> Spectrum
Digital health technology for non-motor symptoms in people with Parkinson's disease: Futile or future?
Cross-sectional analysis of the Parkinson’s disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life
Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease
Access and Attitudes Toward Palliative Care Among Movement Disorders Clinicians
Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy
Non-Motor Symptoms Assessed by Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale in Parkinson's Disease in Selected Asian Populations
Quantitative demonstration of the efficacy of night-time apomorphine infusion to treat nocturnal hypokinesia in Parkinson's disease using wearable sensors
Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force
Unmet needs in Parkinson's disease: New horizons in a changing landscape
Neutralizing Antibody and Botulinum Toxin Therapy: A Systematic Review and Meta-analysis
Evidence-based guideline: Treatment of tardive syndromes
Parkinson’s Disease: Hoehn and Yahr Scale